Table 1 Clinicopathologic features and surgery method in 23 cases of inflammatory myofibroblastic tumor
Age | |
 Range | 2–80 |
 Mean | 35.9 |
Sex | |
 Male | 11 (47.8%) |
 Female | 12 (52.2%) |
Tumor location | |
 Upper third | 10 (43.5%) |
 Middle third | 6 (26.1%) |
 Lower third | 5 (21.7%) |
 Unknown | 2 (8.7%) |
Tumor size (cm) | |
 Range | 1.8–15 |
 Mean | 7.4 |
Mitosis (HPF) | |
 Range | 1–2 |
 Mean | 1 |
ALK | |
 Positive | 8 (34.8%) |
 Negative | 6 (26.1%) |
 Not available | 9 (39.1%) |
Surgery | |
 Distal gastrectomy | 3 (13.0%) |
 Partial gastrectomy | 9 (39.1%) |
 Total gastrectomy | 1 (4.3%) |
 Wedge resection | 1 (4.3%) |
 Partial gastrectomy with other organ resection | 4 (17.4%) |
 Sleeve gastrectomy | 1 (4.3%) |
 Combined laparoscopic and endoscopic gastric wedge resection | 1 (4.3%) |
 EMR | 1 (4.3%) |
 Unknown and other | 2 (8.7%) |